Latigene Tablet (Ranitidine Hydrochloride)
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Ilhwa Co., Ltd.
MFDS item code 201402490 · Approved 2014.05.30
This product's status changed to Expired on 2024.05.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson's syndrome
This medication is used to suppress gastric acid secretion and aid in the healing of ulcers in conditions such as gastric and duodenal ulcers and Zollinger-Ellison syndrome. It is also effective in treating gastroesophageal reflux disease and is used preoperatively for the prevention of Mendelson's syndrome. Additionally, it helps treat ulcers after surgery and gastric ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It improves gastric mucosal lesions that occur during acute exacerbations of acute and chronic gastritis and is also used to alleviate upper gastrointestinal bleeding. It is effective in relieving symptoms of excess gastric acid, such as heartburn and sour belching. Overall, the medication is useful for improving the health of the stomach and digestive tract.
1. Adults Administer ranitidine 150 mg orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer this drug at 150 mg twice daily orally, or 300 mg once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The same dosage regimen applies to concomitant therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. These conditions usually heal within 4 weeks, or within 8 weeks for conditions caused by nonsteroidal anti-inflammatory drug use, although the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer this drug at 150 mg twice daily for 8 weeks, or 300 mg once daily before bedtime. The dose may be increased to 150 mg 4 times daily for patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with this drug at 150 mg 3 times daily and increase the dose as needed. For severe disease, up to 6 g per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions is usually initially treated with an injectable preparation. Once oral administration is possible, switch to oral administration of this drug at 150 mg twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 150 mg of this drug 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer this drug at 150 mg once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment whose creatinine clearance is 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the plasma concentration of the drug; therefore, adjust the dosing schedule to administer the drug immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
For patients 12 years of age and older, the dose is 75 mg per dose, administered orally twice daily (oral solution only). For patients 8 〜 18 years of age, up to 150 mg per dose (2 mg per kg of body weight) may be administered twice daily.
This drug should not be used in patients who have had allergic reactions to its components. It should also not be administered to patients with the rare metabolic disorder known as acute porphyria. This drug contains lactose, so patients with lactose intolerance or specific genetic lactose breakdown disorders should not take it. Patients with impaired kidney function may have delayed elimination of this drug, necessitating dose adjustments, and those with decreased liver function should also be used with caution. Those with a history of drug hypersensitivity, elderly patients, and those taking non-steroidal anti-inflammatory drugs (NSAIDs) should use this medication more cautiously. This drug can mask symptoms of gastric cancer, so patients with gastric ulcers or new or changed dyspeptic symptoms, particularly those aged 40 and over, should check for malignancy before treatment. Patients with gastric or duodenal ulcers infected with Helicobacter pylori require eradication therapy. During the course of treatment, patients may experience allergic reactions or shock symptoms, blood abnormalities, liver dysfunction, cardiac rhythm irregularities, gastrointestinal symptoms, psychiatric neurological abnormalities, muscle pain, skin rashes, or other side effects, and should immediately consult a healthcare professional if any symptoms occur. It is important to closely monitor the patient's condition during treatment and to conduct regular blood tests and liver and kidney function tests. Elderly patients or those with chronic conditions may have an increased risk of pneumonia. Additionally, if dizziness or drowsiness occurs after taking this medicine, patients should avoid driving or operating dangerous machinery. This drug may affect the absorption or metabolism of other drugs, so patients should inform their healthcare provider of any concurrent medications, particularly in the case of anticoagulants, which require close monitoring of coagulation status. Women who are pregnant, potentially pregnant, or breastfeeding should use this drug cautiously, only when necessary. Safety for children has not been adequately established, so extra care is needed when administering to children. Elderly patients may have an increased blood concentration of this medication due to decreased kidney function, necessitating dose adjustments and extended dosing intervals. Taking this drug may lead to false positive results in some urine tests, so care should be taken regarding testing methods. In case of overdose, it is important to receive appropriate treatment such as vomiting or gastric lavage, and if necessary, the drug can be removed by dialysis. This drug should be kept out of reach of children and transferring it to other containers should be avoided to maintain quality and prevent accidents. This drug can promote bacterial growth in the stomach by reducing gastric acid secretion, so additional care such as eye examinations may be needed with prolonged use.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly sealed container that blocks light, and it is important to keep it in a dry place free from moisture.
White, round, film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Ilhwa Co., Ltd.
Ranitidine Hydrochloride 168mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 336mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 112mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.